AdooQ BioScience is a supplier of biochemicals located in Irvine, CA since 2006. In the past five years, we have been a renowned name engaged in manufacturing and supplying small molecule inhibitors including kinase inhibitors on kinds of signal pathway, such as PI3K, AKT, HDAC, MARP etc.
Company WebsiteSB225002 is a potent, and selective CXCR2 antagonist with IC50 of 22 nM for inhibiting interleukin IL-8 binding to CXCR2, > 150-fold selectivity over the other 7-TMRs tested.
More Information Supplier PageSB225002 is a potent, and selective CXCR2 antagonist with IC50 of 22 nM for inhibiting interleukin IL-8 binding to CXCR2, > 150-fold selectivity over the other 7-TMRs tested.
More Information Supplier PageSB269652 is a new chemical probe that can differentiate D2R monomers from dimers or oligomers depending on the observed pharmacology.
More Information Supplier PageSB269652 is a new chemical probe that can differentiate D2R monomers from dimers or oligomers depending on the observed pharmacology.
More Information Supplier PageSB269652 is a new chemical probe that can differentiate D2R monomers from dimers or oligomers depending on the observed pharmacology.
More Information Supplier PageSB271046 is a potent, selective and orally active 5-HT6 receptor antagonist with pKi of 8.9, exhibits 200-fold greater selectivity over other 5-HT receptor subtypes.
More Information Supplier PageSB271046 is a potent, selective and orally active 5-HT6 receptor antagonist with pKi of 8.9, exhibits 200-fold greater selectivity over other 5-HT receptor subtypes.
More Information Supplier PageSB271046 is a potent, selective and orally active 5-HT6 receptor antagonist with pKi of 8.9, exhibits 200-fold greater selectivity over other 5-HT receptor subtypes.
More Information Supplier PageSB590885 is a selective small-molecule inhibitor of the B-Raf kinase and Ki app values are 0.16 and 1.72 nM for B-Raf and c-Raf respectively.
More Information Supplier PageSB590885 is a selective small-molecule inhibitor of the B-Raf kinase and Ki app values are 0.16 and 1.72 nM for B-Raf and c-Raf respectively.
More Information Supplier PageSB590885 is a selective small-molecule inhibitor of the B-Raf kinase and Ki app values are 0.16 and 1.72 nM for B-Raf and c-Raf respectively.
More Information Supplier PageSB590885 is a selective small-molecule inhibitor of the B-Raf kinase and Ki app values are 0.16 and 1.72 nM for B-Raf and c-Raf respectively.
More Information Supplier PageSB939 is an oral inhibitor of HDAC, selective for class I, II and IV HDACs and displays an IC50 value of 77 nM in an in vitro HDAC1 activity assay.
More Information Supplier PageSB939 is an oral inhibitor of HDAC, selective for class I, II and IV HDACs and displays an IC50 value of 77 nM in an in vitro HDAC1 activity assay.
More Information Supplier PageSB939 is an oral inhibitor of HDAC, selective for class I, II and IV HDACs and displays an IC50 value of 77 nM in an in vitro HDAC1 activity assay.
More Information Supplier PageSB939 is an oral inhibitor of HDAC, selective for class I, II and IV HDACs and displays an IC50 value of 77 nM in an in vitro HDAC1 activity assay.
More Information Supplier PageSB939 is an oral inhibitor of HDAC, selective for class I, II and IV HDACs and displays an IC50 value of 77 nM in an in vitro HDAC1 activity assay.
More Information Supplier PageSBC-115076 is an anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds, for the treatment and/or prevention of cardiovascular diseases.
More Information Supplier PageSBC-115076 is an anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds, for the treatment and/or prevention of cardiovascular diseases.
More Information Supplier PageSBC-115076 is an anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds, for the treatment and/or prevention of cardiovascular diseases.
More Information Supplier PageSBE 13 HCl is a selective inhibitor of PLK1 (IC50 values are 200 pM, 875 nM and 66 ??M for PLK1, PLK3 and PLK2 respectively).
More Information Supplier PageSBE 13 HCl is a selective inhibitor of PLK1 (IC50 values are 200 pM, 875 nM and 66 ??M for PLK1, PLK3 and PLK2 respectively).
More Information Supplier PageSBE 13 HCl is a selective inhibitor of PLK1 (IC50 values are 200 pM, 875 nM and 66 ??M for PLK1, PLK3 and PLK2 respectively).
More Information Supplier PageSBE 13 HCl is a selective inhibitor of PLK1 (IC50 values are 200 pM, 875 nM and 66 ??M for PLK1, PLK3 and PLK2 respectively).
More Information Supplier PageSBI-0206965 is a potent, selective and cell permeable autophagy kinase ULK1 inhibitor with IC50 of 108 nM for ULK1 kinase activity and 711 nM for the highly related kinase ULK2 .
More Information Supplier PageSBI-0206965 is a potent, selective and cell permeable autophagy kinase ULK1 inhibitor with IC50 of 108 nM for ULK1 kinase activity and 711 nM for the highly related kinase ULK2 .
More Information Supplier PageSBI-0206965 is a potent, selective and cell permeable autophagy kinase ULK1 inhibitor with IC50 of 108 nM for ULK1 kinase activity and 711 nM for the highly related kinase ULK2 .
More Information Supplier PageSC 57461A is a potent and competitive inhibitor of recombinant human leukotriene A4 hydrolase in vitro (Askonas et al., 2002).
More Information Supplier PageSC 57461A is a potent and competitive inhibitor of recombinant human leukotriene A4 hydrolase in vitro (Askonas et al., 2002).
More Information Supplier PageSC 57461A is a potent and competitive inhibitor of recombinant human leukotriene A4 hydrolase in vitro (Askonas et al., 2002).
More Information Supplier PageSC-514 is an orally active, ATP-competitive IKK?? inhibitor (IC50 = 3 – 12 ??M) that displays > 10-fold selectivity over 28 other kinases including JNK, p38, MK2 and ERK.
More Information Supplier PageSC-514 is an orally active, ATP-competitive IKK?? inhibitor (IC50 = 3 – 12 ??M) that displays > 10-fold selectivity over 28 other kinases including JNK, p38, MK2 and ERK.
More Information Supplier PageSC-514 is an orally active, ATP-competitive IKK?? inhibitor (IC50 = 3 – 12 ??M) that displays > 10-fold selectivity over 28 other kinases including JNK, p38, MK2 and ERK.
More Information Supplier PageSC-514 is an orally active, ATP-competitive IKK?? inhibitor (IC50 = 3 – 12 ??M) that displays > 10-fold selectivity over 28 other kinases including JNK, p38, MK2 and ERK.
More Information Supplier PageSC-514 is an orally active, ATP-competitive IKK?? inhibitor (IC50 = 3 – 12 ??M) that displays > 10-fold selectivity over 28 other kinases including JNK, p38, MK2 and ERK.
More Information Supplier Page
